Blood/Immune System Cells TRIZ Cases
- Closed Bioreactor for Autologous T Cell Manufacturing
Rocking bioreactors automate media exchange and transduction to reduce labor intensity and contamination risks in cell therapy manufacturing.
- Adoptive Transfer of Primed B Cells for Hybridoma Generation
Adoptive transfer of primed B cells bypasses pre-existing antibody interference to boost specific cell counts.
- Vx-001 Vaccine Targeting Cryptic TERT Epitopes for Non-Immunogenic Tumors
Vx-001 vaccine overcomes non-immunogenic tumor resistance by using optimized cryptic TERT peptides to induce cytotoxic T lymphocyte responses.
- Immune Killer Cell Culture Using ConA Mitogens
Plant-derived mitogens stimulate NK and T cell expansion while removing zoonotic infection risks from animal proteins.
- Ex Vivo Activated T-Cell Composition for Targeted Cancer Therapy
Fixed ratio ex vivo activated lymphocytic subsets enhance targeting specificity in personalized cancer therapies.
- Cortical Organoids Mimicking Brain Oscillations
A protocol generates cortical organoids from human pluripotent stem cells that produce low-frequency electrical oscillations.
- Hematopoietic Progenitor Cell Marker Selection for CD8+ T Cell Production
Separating hematopoietic progenitor cells via specific marker profiles to produce CD4/CD8 double positive cells.
- In-Vitro Lymphoid Cell Clusters for Human Immune Response Modeling
An in-vitro cell cluster maintains functional lymphoid organization to produce antigen-specific antibodies and simulate adaptive immunity.
- Degradable 3D Matrix for Circulating Tumor Cell Recovery
Enzymatic degradation of a porous 3D matrix releases viable target cells, enabling early detection without complex diagnostic infrastructure.
- Regulatory T Cell Lineage Stability via Subset Segmentation
Enriched regulatory T cell composition with naive and central memory subsets improves lineage stability.
- Vascular Endothelial Cell Induction via Matrix Segmentation
Segmenting differentiation into stages with BMP4 and VEGF overcomes low purity and efficiency bottlenecks.
- Cell-Based Flow Cytometry Assay for Neutralizing Antibodies
A cell-based flow cytometry method detects neutralizing factors in patient fluids using receptor-expressing cells.
- Magnetic Particle NK Cell Culture Composition
Surface-bound cytokines on magnetic carriers replace K562 feeder cells to proliferate natural killer cells while eliminating immune rejection risks.
- Memory T Cell Expansion via Cytokine Optimization
Replacing IL-2 with IL-21 and IL-7 prevents terminal differentiation, sustaining expansion without sacrificing long-term survival.
- T Regulatory Cell Generation via Thymic Microenvironment Recapitulation
A method generates T regulatory cells by exposing pluripotent stem cells to thymic medullary epithelial cells.
- Avian B Cell Antibody Diversification via PI3Kα Inhibition
Suppressing PI3Kα activity in avian B cells overcomes immune tolerance barriers to generate high-affinity antibodies.
- Reprogramming Myeloid Progenitors to HLA-Matched Immune Cells
Exogenous transcription factors reverse myeloid lineage potential to generate patient-specific immune cells.